Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation

BACKGROUND: There is evidence suggesting that most thromboembolic complications could be prevented with adequate pharmacological anticoagulation. We estimated the direct health care costs of anticoagulant treatment with oral vitamin K antagonists in patients diagnosed with non-valvular atrial fibril...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidalgo-Vega, Álvaro, Askari, Elham, Vidal, Rosa, Aranda-Reneo, Isaac, Gonzalez-Dominguez, Almudena, Ivanova, Alexandra, Ene, Gabriela, Llamas, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914362/
https://www.ncbi.nlm.nih.gov/pubmed/24479444
http://dx.doi.org/10.1186/1472-6963-14-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914362/
https://www.ncbi.nlm.nih.gov/pubmed/24479444
http://dx.doi.org/10.1186/1472-6963-14-46

Ejemplares similares